1 - 25 of 77 results for author:"Funk C.D." in Literature citations
Results Customize
› Repeat search in UniProtKB (19)
| Prostaglandin receptor EP4 in abdominal aortic aneurysms. Cao R.Y., St Amand T., Li X., Yoon S.H., Wang C.P., Song H., Maruyama T., Brown P.M., Zelt D.T., Funk C.D. Am. J. Pathol. 181:313-321(2012) · Mapped (20) |
| Vascular COX-2 modulates blood pressure and thrombosis in mice. Yu Y., Ricciotti E., Scalia R., Tang S.Y., Grant G., Yu Z., Landesberg G., Crichton I., Wu W., Pure E. et al. Sci Transl Med 4:132ra54-132ra54(2012) · Mapped (3) |
| The cysteinyl leukotriene 2 receptor mediates retinal edema and pathological neovascularization in a murine model of oxygen-induced retinopathy. Barajas-Espinosa A., Ni N.C., Yan D., Zarini S., Murphy R.C., Funk C.D. FASEB J. 26:1100-1109(2012) · Mapped (2) |
| Pulmonary oxidative stress is increased in cyclooxygenase-2 knockdown mice with mild pulmonary hypertension induced by monocrotaline. Seta F., Rahmani M., Turner P.V., Funk C.D. PLoS ONE 6:e23439-e23439(2011) · Mapped (3) |
| Characterization of the cysteinyl leukotriene 2 receptor in novel expression sites of the gastrointestinal tract. Barajas-Espinosa A., Ochoa-Cortes F., Moos M.P., Ramirez F.D., Vanner S.J., Funk C.D. Am. J. Pathol. 178:2682-2689(2011) · Mapped (2) |
| Disruption of the 12/15-lipoxygenase gene (Alox15) protects hyperlipidemic mice from nonalcoholic fatty liver disease. Martinez-Clemente M., Ferre N., Titos E., Horrillo R., Gonzalez-Periz A., Moran-Salvador E., Lopez-Vicario C., Miquel R., Arroyo V., Funk C.D. et al. Hepatology 52:1980-1991(2010) · Mapped (4) |
| Dual 12/15- and 5-lipoxygenase deficiency in macrophages alters arachidonic acid metabolism and attenuates peritonitis and atherosclerosis in ApoE knock-out mice. Poeckel D., Zemski Berry K.A., Murphy R.C., Funk C.D. J. Biol. Chem. 284:21077-21089(2009) · Mapped (26) |
| Renal and cardiovascular characterization of COX-2 knockdown mice. Seta F., Chung A.D., Turner P.V., Mewburn J.D., Yu Y., Funk C.D. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296:R1751-60(2009) · Mapped (3) |
| Genetic and pharmacological inhibition of the 5-lipoxygenase/leukotriene pathway in atherosclerotic lesion development in ApoE deficient mice. Cao R.Y., St Amand T., Grabner R., Habenicht A.J., Funk C.D. Atherosclerosis 203:395-400(2009) · Mapped (13) |
| Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transport. Moos M.P., Mewburn J.D., Kan F.W., Ishii S., Abe M., Sakimura K., Noguchi K., Shimizu T., Funk C.D. FASEB J. 22:4352-4362(2008) · Mapped (4) |
| Endothelial cysteinyl leukotriene 2 receptor expression mediates myocardial ischemia-reperfusion injury. Jiang W., Hall S.R., Moos M.P., Cao R.Y., Ishii S., Ogunyankin K.O., Melo L.G., Funk C.D. Am. J. Pathol. 172:592-602(2008) · Mapped (8) |
| 5-Lipoxygenase/cyclooxygenase-2 cross-talk through cysteinyl leukotriene receptor 2 in endothelial cells. Lotzer K., Jahn S., Kramer C., Hildner M., Nusing R., Funk C.D., Habenicht A.J. Prostaglandins Other Lipid Mediat. 84:108-115(2007) · Mapped (8) |
| Angiotensin II-induced abdominal aortic aneurysm occurs independently of the 5-lipoxygenase pathway in apolipoprotein E-deficient mice. Cao R.Y., Adams M.A., Habenicht A.J., Funk C.D. Prostaglandins Other Lipid Mediat. 84:34-42(2007) · Mapped (19) |
| Selective 5-lipoxygenase expression in Langerhans cells and impaired dendritic cell migration in 5-LO-deficient mice reveal leukotriene action in skin. Doepping S., Funk C.D., Habenicht A.J., Spanbroek R. J. Invest. Dermatol. 127:1692-1700(2007) · Mapped (6) |
| PKC-dependent regulation of the receptor locus dominates functional consequences of cysteinyl leukotriene type 1 receptor activation. Deshpande D.A., Pascual R.M., Wang S.W., Eckman D.M., Riemer E.C., Funk C.D., Penn R.B. FASEB J. 21:2335-2342(2007) · Mapped (3) |
| Is there a role for the macrophage 5-lipoxygenase pathway in aortic aneurysm development in apolipoprotein E-deficient mice? Funk C.D., Cao R.Y., Zhao L., Habenicht A.J. Ann. N. Y. Acad. Sci. 1085:151-160(2006) · Mapped (15) |
| Targeted cyclooxygenase gene (ptgs) exchange reveals discriminant isoform functionality. Yu Y., Fan J., Hui Y., Rouzer C.A., Marnett L.J., Klein-Szanto A.J., FitzGerald G.A., Funk C.D. J. Biol. Chem. 282:1498-1506(2007) · Mapped (8) |
| Genetic model of selective COX2 inhibition reveals novel heterodimer signaling. Yu Y., Fan J., Chen X.S., Wang D., Klein-Szanto A.J., Campbell R.L., FitzGerald G.A., Funk C.D. Nat. Med. 12:699-704(2006) · Mapped (8) |
| Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. Cheng Y., Wang M., Yu Y., Lawson J., Funk C.D., Fitzgerald G.A. J. Clin. Invest. 116:1391-1399(2006) · Mapped (17) |
| Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells. Uzonyi B., Lotzer K., Jahn S., Kramer C., Hildner M., Bretschneider E., Radke D., Beer M., Vollandt R., Evans J.F. et al. Proc. Natl. Acad. Sci. U.S.A. 103:6326-6331(2006) · Mapped (10) |
| 12/15-Lipoxygenase gene disruption and vitamin E administration diminish atherosclerosis and oxidative stress in apolipoprotein E deficient mice through a final common pathway. Zhao L., Pratico D., Rader D.J., Funk C.D. Prostaglandins Other Lipid Mediat. 78:185-193(2005) · Mapped (15) |
| Absence of 12/15 lipoxygenase reduces brain oxidative stress in apolipoprotein E-deficient mice. Chinnici C.M., Yao Y., Ding T., Funk C.D., Pratico D. Am. J. Pathol. 167:1371-1377(2005) · Mapped (2) |
| The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice. Moos M.P., John N., Grabner R., Nossmann S., Gunther B., Vollandt R., Funk C.D., Kaiser B., Habenicht A.J. Arterioscler. Thromb. Vasc. Biol. 25:2386-2391(2005) · Mapped (13) |
| The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis. Lotzer K., Funk C.D., Habenicht A.J. Biochim. Biophys. Acta 1736:30-37(2005) · Mapped (8) |
| Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress. Tietge U.J., Pratico D., Ding T., Funk C.D., Hildebrand R.B., Van Berkel T., Van Eck M. J. Lipid Res. 46:1604-1614(2005) · Mapped (13) |